UPS has completed the acquisition of MNX Global Logistics (MNX), a global time-critical logistics provider.
MNX’s expertise in transporting radiopharmaceuticals and temperature-sensitive products will help UPS Healthcare and its clinical trial logistics subsidiary, Marken, meet the growing demand for these services in the healthcare industry, particularly in the USA, Europe and Asia.
The acquisition of MNX is part of UPS’s ongoing strategy to invest in new technologies and capabilities.